Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Letter From The Editor

Often when a diabetes patient goes out of the house, they have a whole backpack full of stuff, including meters, strips, lancets, glucose tabs, insulin pens or extra pump sets, a cell phone and maybe a CGMS device.

Keeping up with their bag of diabetes supplies can be a burden that makes a patient not care if they grab it or if they have everything they need. This week, the FDA gave approval to the new Dexcom Continuous Glucose meter. Using this system, the patient has less to carry and if they are a child, there is less to lose or leave behind. Check out item #2 to learn more.

For your newly diagnosed kids, these devices can make a big difference, as you can see by reading Item #8, which tells how starting with technology from day 1 is probably a good idea.



Announcements: Sunday, August 30, 7PM ET

From "dLife investigates diabetes care in America's prisons and jails. And, more Real People, Real stories as we visit a woman who has a high flying way of staying fit and in control. Plus, Chef Michel Nischan gives a comfort food favorite — meatloaf — a low-carb makeover." Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at


We can make a difference!


Dave Joffe, Editor-in-chief

 … Read More

Scroll down for items in the current newsletter


Insulet initiated a lot-specific voluntary recall of 40,846 boxes (10 Pods per box) of the OmniPod (Pod) Insulin Management System. This field corrective action is due to the possibility that some of the Pods from these lots may have a higher rate of failure than Insulet's current manufacturing standards. For more information as to the lot numbers, go to:


Empagliflozin/metformin is new combo medication for type 2 diabetes. More information coming in next week's newsletter.

Tool for your Practice

altWhat every patient needs to have to save their lives. For more information about preparing your diabetes supplies for an emergency, watch this "How to Pack Your Kit" video. A list of what you need from Eli Lilly -- English version / Spanish version.

Product of the Week

altLast month, Google announced their partnership with Novartis Pharmaceuticals to develop a contact lens that is capable of monitoring glucose levels from tears. See Item #1.

Mobile App of the Week 

iRecordit Diabetes Sugar Glucose and Health Tracker


The only application you'll need to record personal health-related info like blood sugar/glucose, blood pressure, weight, cholesterol, nutrition, exercise, medications, lab results, general notes, and more. More information.






Test Your Knowledge Question #796

A 41-year-old patient with a BMI of 39 kg/m2 returns for a follow-up visit 3 months after initiating metformin. She is highly sensitive to her weight and has tried to implement lifestyle modifications, but is finding it difficult to make any meaningful changes in her diet or exercise routines. Her current A1C is 7.7%, with a target goal A1C<7%. In addition to discussing consideration of bariatric surgery, which drug class might you add?

A. Thiazolidinedione
B. Sulfonylurea
C. DDP-4 inhibitor
D. GLP-1 receptor agonist

For the complete question and answer, just follow this link. 

Diabetes In Control Has Over 16000 Studies & Articles In Our Archives

Quote of the Week!

"How wonderful it is that nobody need wait a single moment before starting to improve the world."
         ...Anne Frank


Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week's newsletter: 

Ashley Spies, USF College of Pharmacy
Shatera Peace, FAMU
Thao Luutran, LECOM
L'Shantey Wells, Creighton College of Pharmacy
Diane Jules, USF College of Pharmacy

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Lois Exelbert,

Category: Nursing
Credits: 1